Synergy Pharmaceuticals, Inc. (SGYP) financial statements (2022 and earlier)

Company profile

Business Address 420 LEXINGTON AVENUE
NEW YORK, NY 10170
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments136,98682,387111,750196,36768,15732,502
Cash and cash equivalents136,98682,38761,653146,47018,13012,416
Short-term investments  50,09749,89750,02720,086
Receivables6,491     
Inventory, net of allowances, customer advances and progress billings17,2145,640  
Inventory17,2145,640    
Prepaid expense and other current assets1,547
Other undisclosed current assets4,4698893,3053,8363,718 
Total current assets:165,16088,916115,055200,20371,87534,049
Noncurrent Assets
Property, plant and equipment1,13459353164258930
Long-term investments and receivables     3,306
Due from related parties     3,306
Deferred costs   12,336  
Other undisclosed noncurrent assets3123433431639420
Total noncurrent assets:1,44693687413,1416833,356
TOTAL ASSETS:166,60689,852115,929213,34472,55837,405
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities38,14729,43019,57918,33115,6767,315
Accounts payable23,25615,58413,26313,86913,5425,255
Accrued liabilities14,65813,5524,3281,9622,1342,060
Interest and dividends payable2332941,9882,500  
Total current liabilities:38,14729,43019,57918,33115,6767,315
Noncurrent Liabilities
Long-term debt and lease obligation98,66022,665151,241200,000  
Long-term debt, excluding current maturities98,66022,665151,241200,000  
Liabilities, other than long-term debt18,0152163221721,5345,258
Other liabilities433     
Derivative instruments and hedges, liabilities17,5822163221721,5345,258
Other undisclosed noncurrent liabilities17,302     
Total noncurrent liabilities:133,97722,881151,563200,1721,5345,258
Total liabilities:172,12452,311171,142218,50317,21012,573
Stockholders' equity
Stockholders' equity attributable to parent(5,518)37,541(55,213)(5,159)55,34824,832
Common stock25201111107
Additional paid in capital801,787620,513329,161261,715226,515133,878
Accumulated deficit(807,330)(582,992)(384,385)(266,885)(171,177)(109,053)
Total stockholders' equity:(5,518)37,541(55,213)(5,159)55,34824,832
TOTAL LIABILITIES AND EQUITY:166,60689,852115,929213,34472,55837,405

Income statement (P&L) ($ in thousands)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues16,820     
Cost of revenue(8,811)     
Gross profit:8,009     
Operating expenses(230,208)(145,286)(99,822)(94,278)(62,311)(38,237)
Other undisclosed operating income     2
Operating loss:(222,199)(145,286)(99,822)(94,278)(62,311)(38,235)
Nonoperating income (expense)(2,139)(53,321)(17,678)(1,430)187(1,209)
Investment income, nonoperating   (2,464)59218
Other nonoperating income 121 83 506
Interest and debt expense(1,209)(6,921)(4,566)(2,911)(21) 
Net loss attributable to parent:(225,547)(205,528)(122,066)(98,619)(62,145)(39,444)
Other undisclosed net income available to common stockholders, basic1,2096,9214,5662,91121 
Net loss available to common stockholders, diluted:(224,338)(198,607)(117,500)(95,708)(62,124)(39,444)

Comprehensive Income ($ in thousands)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(225,547)(205,528)(122,066)(98,619)(62,145)(39,444)
Comprehensive loss, net of tax, attributable to parent:(225,547)(205,528)(122,066)(98,619)(62,145)(39,444)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: